CASSAVA SCIENCES INC. - COMMON STOCK
26.48
22-November-24 15:44:58
15 minutes delayed
Stocks
-5.70
-17.71%
Today's range
26.02 - 31.40
ISIN
N/A
Source
NASDAQ
-
New Data by Academic Researchers Highlights Biological Activity of Simufilam on Filamin A
08 May 2023 08:15:00 By Nasdaq GlobeNewswire
-
Cassava Sciences Reports Q1 2023 Financial Results and Operating Updates
01 May 2023 08:00:00 By Nasdaq GlobeNewswire
-
Cassava Sciences to Present at the 2023 H.C. Wainwright Investor Conference
26 Apr 2023 08:12:00 By Nasdaq GlobeNewswire
-
Cassava Sciences Reports Full-year 2022 Financial Results and Operating Updates
28 Feb 2023 08:15:00 By Nasdaq GlobeNewswire
-
08 Feb 2023 08:15:00 By Nasdaq GlobeNewswire
-
24 Jan 2023 08:15:00 By Nasdaq GlobeNewswire
-
Cassava Sciences Mourns the Death of Board Member and Officer Nadav Friedmann, PhD, MD
20 Dec 2022 08:15:00 By Nasdaq GlobeNewswire
-
06 Dec 2022 08:15:00 By Nasdaq GlobeNewswire
-
Cassava Sciences Announces Closing of $50 Million Registered Direct Offering
22 Nov 2022 11:29:58 By Nasdaq GlobeNewswire
-
Cassava Sciences Announces $50 Million Registered Direct Offering of Common Stock
18 Nov 2022 12:30:58 By Nasdaq GlobeNewswire
-
Cassava Sciences Reports Third Quarter Financial Results for 2022 and Business Updates
07 Nov 2022 08:00:01 By Nasdaq GlobeNewswire
-
Cassava Sciences Files Lawsuit Against Perpetrators of “Short and Distort” Campaign
03 Nov 2022 08:15:00 By Nasdaq GlobeNewswire
-
Cassava Sciences Announces Expansion of Leadership Team
27 Oct 2022 08:15:00 By Nasdaq GlobeNewswire
-
Cassava Sciences Announces Initiation of an Open-label Extension Study
13 Oct 2022 08:15:00 By Nasdaq GlobeNewswire
-
Cassava Sciences to Present at the H.C. Wainwright Global Investment Conference
08 Sep 2022 08:15:00 By Nasdaq GlobeNewswire
-
No Evidence of Data Manipulation in Science Publication on Simufilam
18 Aug 2022 08:15:00 By Nasdaq GlobeNewswire
-
03 Aug 2022 08:15:00 By Nasdaq GlobeNewswire
-
Cassava Sciences Responds to Media Reports
27 Jul 2022 12:36:21 By Nasdaq GlobeNewswire
-
05 May 2022 08:00:03 By Nasdaq GlobeNewswire
-
Cassava Sciences Invited to Participate in B. Riley Securities’ Neuroscience Conference
25 Apr 2022 08:00:00 By Nasdaq GlobeNewswire